PhRMA (@PhRMA) / X

PhRMA

16.9K posts

PhRMA

@PhRMA

Representing America’s biopharma & biotech companies. Shaping policy so science thrives & patients benefit.

Washington, DC

Joined February 2010

Pinned
PhRMA
@PhRMA
18h
When your child is sick, time is everything. ⏳ Americans get new medicines 3 years faster than other countries. But if Washington copies other countries’ price control policies, we could be forced to wait, too. Our new ad highlights what's at stake. Watch now:
00:00
New “America Cures” ad highlights that U.S. patients get new medicines
From phrma.org
513
PhRMA
@PhRMA
Jun 13
The U.S. is at risk of losing its lead in medical innovation. While we debate MFN price controls, China is accelerating clinical trials and expanding its leadership in oncology and immunotherapy. If we hand over the future of medicine to China, patients will pay the price.
Harmful U.S. policies will help drive China’s global leadership in biopharmaceutical innovation
From phrma.org
609
PhRMA
@PhRMA
Jun 12
77% of insured Americans said they were interested in learning more about new websites that allow patients to purchase medicines directly from manufacturers. Can you relate? Visit America’s Medicines to see how greater transparency helps patients navigate health care decisions.
America's Medicines
From americasmedicines.com
333
PhRMA
@PhRMA
Jun 11
This week, biopharmaceutical researchers met with over 175 policymaker offices. We are incredibly grateful to the researchers who lent their voices to protect the ecosystem that enables life-saving science. #PhRMAFlyIn26 ow.ly/cPJc50ZaE5F
424
PhRMA
@PhRMA
Jun 10
Today, our researchers are heading to Capitol Hill to meet directly with lawmakers and congressional staff to advocate for the pro-innovation policies that ensure America stays a global leader in medical discovery. #PhRMAFlyIn26
476
PhRMA
@PhRMA
Jun 9
Our researchers are convening in DC today for #PhRMAFlyIn26! Tomorrow, they will go to Capitol Hill to advocate for the policies needed to deliver new treatments to patients. Follow along on Instagram >>> ow.ly/S0iF50Z9ubx
398
PhRMA
@PhRMA
Jun 9
Patients in other high-income countries have access to just 36% of new medicines. U.S. patients have access to 88%. That gap is driven by policy choices that delay or restrict access. We need policies that support innovation and ensure patients get the treatments they need.
Access to New Medicines
From phrma.org
3.2K
PhRMA
@PhRMA
Jun 7
Today is National Cancer Survivors Day, a time to celebrate life, honor resilience and look ahead at the incredible science bringing hope to millions. Hear from some of our companies on the future of cancer treatments and the investments being made to deliver new treatments and
00:00
736
PhRMA
@PhRMA
Jun 6
Cell and gene therapies are changing the future of medicine. But many Medicare patients still face barriers to accessing these innovative treatments. Our health care system must keep pace with innovation so patients can benefit from these breakthroughs.
Future of Medicine
From phrma.org
554
PhRMA
@PhRMA
Jun 6
Hospitals are converting to nonprofits to tap 340B revenue. This begs the question: is this massive federal program supporting patients or being exploited to boost hospital profits?
Private equity's new play? Become a nonprofit to profit off 340B.
From phrma.org
665
PhRMA
@PhRMA
Jun 5
June is Alzheimer’s & Brain Awareness Month — a time to recognize the millions of patients, families and caregivers impacted by Alzheimer’s disease and renew our commitment to advancing new treatments and cures. For decades, Alzheimer’s was considered one of medicine’s greatest
380
PhRMA
@PhRMA
Jun 5
As policymakers are considering harmful price control policies in the form of Most Favored Nation pricing, patients and caregivers are voicing their concerns. Hear what they have to say:
Patients speak out: MFN won't address my affordability concerns
From phrma.org
434
PhRMA
@PhRMA
Jun 4
On average, it takes 10 to 15 years and $2.6 billion to develop just one medicine, and only 12% of medicines entering clinical trials are successful in getting FDA approval. IP protections, including patents, empower innovators to take on significant risks to develop the best
632